#MapMyIndia Q3 2022 Concall Highlights

Like & Retweet For Better Reach !

Financial Update

1. Total Income ₹52.1Cr, Revenue from operation ₹43.4Cr.
2. Ebitda ₹16.7Cr, Margins 39%.
3. Pat ₹18.5Cr, PAT Margin 36%.
4. Cash and Cash Equivalents ₹389.6 Cr.
5. Total Income for 9M FY22 was ₹174 Cr, Revenue from operation for 9M FY22 was ₹143.4Cr, growth of 37% YOY.
6. Revenue Breakup for 9M FY22- Automotive & Mobile Tech- ₹74Cr, 7. Consumer Tech & Enterprise digital transformation- ₹69 Cr
8. Product Segment for 9M FY22- Platform & IOT- ₹91Cr, Map & Data- ₹52Cr.
9. Ebitda ₹62.7Cr, against ₹33.7Cr 87% YOY growth Margins of 37%
10.Ebitda Margins 44% for 9M FY22.
11.For 9M FY22 - Pat ₹65.2Cr, PAT Margin 37%.
Business Update

1. Q3 was impacted because sales of automotive OEMs were impacted because of semiconductor shortage, which in turn impacted the revenue of the company.

2. As the supply chain recovers quarterly revenues will get normalized.
3. B2B B2B2C revenue contracts that they get are milestone based wherein revenue gets recognized at specific time frames which makes quarterly numbers lumpy. Right way to look at the numbers are on a YOY basis and not quarterly basis.
4. European 4 wheeler OEM went live with MapMyIndia for in-vehicle navigation.

5. Two 2 wheelers OEMS rolling out with mapmyindia to power their connected vehicles and turn by navigation.

6. EV infrastructure & mobility OEM went live with MapMyIndia for battery pack monitoring
7. MapMyIndia shared mobility platform adopted by a leading taxi company.

8. The Ministry of Road Transport & Highways signed a MoU with MapMyIndia for integrating information of accident prone road stretches and promoting MapMyIndia app.
9. Bajaj Finance super app went live with MapMyIndia to power consumer facing mapping services, and for location enhanced digital transformation.
10. QSR company adopted MapMyIndia for evaluating and selecting restaurant sites based on MapMyIndia geospatial data and analytics platform.

11. Government health agency selected MapMyIndia to power GIS (Geospatial Information Services) & location based services.
12. Consumer durables brand adopted MapMyIndia for field workforce management.

13. MapMyIndia released its Vehicle Routing Problem (VRP) solution which can optimize field and fleet operations.
14. MapMyIndia now offers end-to-end drone solutions to customers.
Company acquired a 9.99% stake in Puplimest Pvt Ltd, an automotive tech and augmented reality metaverse tech company for 49.95 Lakhs.
It has 2 Products : Navisor (IoT device to fit with helmet) and Armor (Augmented Reality Handset).

15. Company board also to consider and approve the declaration of interim dividend for the FY 2021-22.
16. Company gave 92 Lakh worth of ESOP this quarter.

17. Company is evaluating and pursuing inorganic opportunities that will help them expand further in the IoT and logistics tech space, as well as in the automotive and augmented reality metaverse tech space.

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Value Educator

Value Educator Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ValueEducator

Jan 31
#Cipla Q3 FY22 concall highlights 💊💉

Like & Retweet for better reach !

1. Revenue growth was at 6%. EBITDA margins were at 22.7% which tracks with their full year guidance despite increased RM and freight costs.
The cost increases were offset by increased share of the complex and chronic launches, continuous rigor on cost control and operating efficiencies.
2. One India reported 13% growth YoY. The core prescription business in India excluding COVID grew strongly by 16% YoY. The branded prescription business is on track to achieve the $1 Billion mark
Read 16 tweets
Jan 31
#PriviSpecialty Q3 22 Concall Highlights 🧪

Like & Retweet for better reach !

Operational Highlights

1. Revenues from operations stood at ₹394 Cr in Q3FY21 with gross margins at 26.64% and EBITDA margins at 15.32%
2. The rise in input cost was overcome as a result of cost improvement.

3. Addition of ₹2.2Cr one time exceptional expense for Mahad overflooded facility
Insurance claims are expected and will be reflected in March FY23

4. Fourth quarter is expected to be much better.
5. Galaxmusk and camphor are huge volume products and will be sold initially in the spot market as most of the requirement by customers is in the second half.Volumes will be reflected in next few quarter as top 25 clients enter annual contracts
Read 14 tweets
Jan 31
#DrReddysLaboratories Q3 FY22 concall highlights 💊💉

Like & Retweet for better reach !

1. Revenue for the quarter was ₹5320 Cr ($715 million). Growth of 8% YoY and declined 8% sequentially. YoY growth is due to good performance across all segments.
2. Sequential decline due to high base in Q2 which had a higher contribution from COVID related products.

3. Gross Profit margin for the quarter was 53.8%, increase of 40 bps QoQ. Gross margins for Global Generics were at 57.8% and PSAI were 22.5%.
4. SG&A spend for the quarter was ₹1541 Cr ($207 million). Increase of 7% YoY and decline of 3% QoQ. YoY increase is due to business expansion and increased spend on sales and marketing activities.
Read 17 tweets
Jan 31
#IntellectDesignArena Q3 22 concall Highlights 🏦💻

Like & retweet for better reach !


Financial Updates -
1. The Revenue for Q3 were up by 33% at 508 cr
2. The companies gross margins are at 60% and has increased 39% YoY
3. EBITDA margins stood at 26.2% grew at 37% YoY, PAT grew by 25% YoY
4. The ARR (Annual Recurring Revenue) stood ar 683 cr
5. The Collection in Q3 were 485 cr, Collection days / DSO stood at 129 days
6. The company has zero debt and cash stands at 431 cr as of Dec 21.
7. SaaS Subscription revenue is up by 113% YoY at 89 cr
8. Licenses revenue is up by 23% YoY at 112cr
9. AMC stood at 82 cr, grew 11% YoY
10. On YTD basis 57% of the revenues are license linked and 43% is Implementation revenue.
Read 18 tweets
Jan 31
#Birlasoft Q3 concall Highlights 💻⌨

Like & Retweet For better reach !

Numbers Updates -

1. The revenue for Q3 was 143.4 Million dollars up by 4.7%QoQ and 20.1% YoY
2. The TCV of the deal wins in Q3 was 185 million dollars, the new business contributing about 121 million dollars, The year to date TCV stood at 474 million dollars.
3. The Enterprise business was up by 6.1% QoQ and 81% YoY
4. Business technology and transformation was up by 4.4% QoQ and 31% YoY
5. Cloud based services was up by 2.7% QoQ and 29%YoY
6. The manufacturing vertical was up by 9% QoQ and 20% YoY
7. Energy and utilities was up by 8.4% QoQ and 20.2% YoY
Read 12 tweets
Jan 31
#ApolloHospitals partners with Amazon - Concall Highlights

Like & Retweet for better reach !!

1. Apollo Pharmacies has signed an agreement with Amazon to list their pharmacy products on amazon.in
2. Apollo already has its own healthcare platform called Apollo 24/7 which offers secure on-line consults, consultation bookings and medicine orders from an Apollo Pharmacy close to their home for delivery at their doorstep in two hours.
Apollo 24/7 has over 30 million registered users.

3. Their omnichannel network generates over 200 million prescriptions annually. With Amazon’s partnership they intend to grow this by 50% over the next 2 years.
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!


0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy


3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!